HEXO strengthens leadership team, appoints Donald Courtney as Chief Operating Officer
Donald Courtney’s experience with innovative, technology-driven companies and his in-depth knowledge of the cannabis industry are great assets to HEXO.
Read More
Select Page
Posted by Invest In Weed | May 22, 2019
Donald Courtney’s experience with innovative, technology-driven companies and his in-depth knowledge of the cannabis industry are great assets to HEXO.
Read MorePosted by Invest In Weed | May 20, 2019
Michael Redard will serve as CURE’s Chief Financial Officer. Josh Held becomes an independent new board member, Bhaumik Patel is CURE’s director of new technologies and Teresa Virgallito will be a scientific advisor.
Read MorePosted by Invest In Weed | May 10, 2019
Present CFO Karyn Barsa, will succeed William Kulczycki as CEO and President of Golden Leaf, effective immediately.
Read MorePosted by Invest In Weed | May 1, 2019
Mr. Chaplin will be available to offer support to the Company for six months following his departure to enable a smooth transition period.
Read MorePosted by Invest In Weed | May 1, 2019
Dr. Paul Tam is a globally recognized expert in the field of nephrology and a pioneer in the development of continuous renal replacement therapy for acute kidney injury.
Read MoreGet stock alerts, news & related alerts straight to your inbox!